Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Clinical PARP inhibitors allosterically induce PARP2 retention on DNA

View through CrossRef
Abstract PARP1 and PARP2 detect DNA breaks, which activates their catalytic production of poly(ADP-ribose) that recruits repair factors and releases PARP1/2 from DNA. PARP inhibitors (PARPi) are used in cancer treatment and target PARP1/2 catalytic activity, interfering with repair and increasing PARP1/2 persistence on DNA damage. Additionally, certain PARPi exert allosteric effects that increase PARP1 retention on DNA. However, no clinical PARPi exhibit this allosteric behavior toward PARP1. In contrast, we show that certain clinical PARPi exhibit an allosteric effect that retains PARP2 on DNA breaks in a manner that depends on communication between the catalytic and DNA-binding regions. Using a PARP2 mutant that mimics an allosteric inhibitor effect, we observed increased PARP2 retention at cellular damage sites. The new PARPi AZD5305 also exhibited a clear reverse allosteric effect on PARP2. Our results can help explain the toxicity of clinical PARPi and suggest ways to improve PARPi moving forward.
Title: Clinical PARP inhibitors allosterically induce PARP2 retention on DNA
Description:
Abstract PARP1 and PARP2 detect DNA breaks, which activates their catalytic production of poly(ADP-ribose) that recruits repair factors and releases PARP1/2 from DNA.
PARP inhibitors (PARPi) are used in cancer treatment and target PARP1/2 catalytic activity, interfering with repair and increasing PARP1/2 persistence on DNA damage.
Additionally, certain PARPi exert allosteric effects that increase PARP1 retention on DNA.
However, no clinical PARPi exhibit this allosteric behavior toward PARP1.
In contrast, we show that certain clinical PARPi exhibit an allosteric effect that retains PARP2 on DNA breaks in a manner that depends on communication between the catalytic and DNA-binding regions.
Using a PARP2 mutant that mimics an allosteric inhibitor effect, we observed increased PARP2 retention at cellular damage sites.
The new PARPi AZD5305 also exhibited a clear reverse allosteric effect on PARP2.
Our results can help explain the toxicity of clinical PARPi and suggest ways to improve PARPi moving forward.

Related Results

Abstract 1718: Schlafen 11 (SLFN11) is a critical determinant of cellular sensitivity to PARP inhibitors
Abstract 1718: Schlafen 11 (SLFN11) is a critical determinant of cellular sensitivity to PARP inhibitors
Abstract Poly(ADP-ribose)polymerases (PARP) are DNA damage sensors and major repair factors for DNA single-strand breaks. Since the discovery of the synthetic lethal...
7 th International Symposium on Enabling Technologies for Life Sciences (ETP)
7 th International Symposium on Enabling Technologies for Life Sciences (ETP)
The seventh in the series of ETP Symposia (see Rapid Communications in Mass Spectrometry 2012, 26 , ...
Serum-dependent and independent regulation of PARP2
Serum-dependent and independent regulation of PARP2
Abstract PARP2 belongs to a family of proteins involved in cell differentiation, DNA damage repair, cellular energy expenditure, chromatin modeli...
DOP15 Clinical relevance of endoscopic peri-appendiceal red patch in Ulcerative Colitis patients
DOP15 Clinical relevance of endoscopic peri-appendiceal red patch in Ulcerative Colitis patients
Abstract Background Recently, increasing evidence is suggesting appendectomy as an alternative treatment approach for ulcerative...
Allosteric activation of PARP2 self-PARylation by SUMO constrains DNA break-dependent catalytic Function
Allosteric activation of PARP2 self-PARylation by SUMO constrains DNA break-dependent catalytic Function
Abstract Poly(ADP-ribose)polymerase 2 (PARP2) is a key player in sensing DNA breaks and initiating DNA damage repair by catalysing the transfer o...
Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry
Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry
Abstract Background Poly(ADP-ribose) polymerases (PARPs) catalyze the formation of poly(ADP-ribose) (pADPr), a post-translational modification in...
Revisiting PARP2 and PARP1 trapping through quantitative live-cell imaging
Revisiting PARP2 and PARP1 trapping through quantitative live-cell imaging
Poly (ADP-ribose) polymerase-1 (PARP1) and 2 (PARP2) are two DNA damage-induced poly (ADP-ribose) (PAR) polymerases in cells and are the targets of PARP inhibitors used for cancer ...

Back to Top